Rajesha Rupaimoole

Rajesha Rupaimoole

UNVERIFIED PROFILE

Are you Rajesha Rupaimoole?   Register this Author

Register author
Rajesha Rupaimoole

Rajesha Rupaimoole

Publications by authors named "Rajesha Rupaimoole"

Are you Rajesha Rupaimoole?   Register this Author

54Publications

3067Reads

26Profile Views

Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells.

EBioMedicine 2019 May 2;43:127-137. Epub 2019 May 2.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.04.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558231PMC
May 2019

ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

Oncotarget 2018 May 18;9(38):25115-25126. Epub 2018 May 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982754PMC
May 2018

Personalized RNA Medicine for Pancreatic Cancer.

Clin Cancer Res 2018 04 12;24(7):1734-1747. Epub 2018 Jan 12.

Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2733DOI Listing
April 2018

Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

Cell Rep 2017 Dec;21(10):2785-2795

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749980PMC
December 2017

Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.

Clin Cancer Res 2017 Sep 13;23(18):5611-5621. Epub 2017 Jun 13.

Department of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-3272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600833PMC
September 2017

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Nat Rev Drug Discov 2017 Mar 17;16(3):203-222. Epub 2017 Feb 17.

Institute for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center Cancer Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd.2016.246DOI Listing
March 2017

A role for miR-34 in colon cancer stem cell homeostasis.

Stem Cell Investig 2016 24;3:42. Epub 2016 Aug 24.

Department of Pathology and Institute of RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/sci.2016.08.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014853PMC
September 2016

Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer.

J Med Imaging (Bellingham) 2016 Jul 10;3(3):036001. Epub 2016 Aug 10.

University of Texas MD Anderson Cancer Center , Department of Cancer Systems Imaging, 1515 Holcombe Boulevard, Houston, Texas 77030, United States.

View Article

Download full-text PDF

Source
http://medicalimaging.spiedigitallibrary.org/article.aspx?do
Publisher Site
http://dx.doi.org/10.1117/1.JMI.3.3.036001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979585PMC
July 2016

Macrophage TGF-1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions.

Int J Clin Med 2016 Jul 21;7(7):496-510. Epub 2016 Jul 21.

Departments of Biochemistry and Clinical Laboratory Sciences, School of Health Professions, University of Texas Health Science Center at San Antonio, San Antonio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4236/ijcm.2016.77055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279341PMC
July 2016

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.

Mol Cancer Ther 2016 06 23;15(6):1344-52. Epub 2016 Mar 23.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893925PMC
June 2016

Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.

Clin Cancer Res 2016 Apr 18;22(7):1713-24. Epub 2015 Nov 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818718PMC
April 2016

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.

Cancer Discov 2016 Mar 10;6(3):235-46. Epub 2016 Feb 10.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783232PMC
March 2016

Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition.

J Immunol 2016 Feb 30;196(3):1412-8. Epub 2015 Dec 30.

Section of Benign Hematology, University of Texas MD Anderson Cancer Center, Houston, TX 77030;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1501886DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724537PMC
February 2016

Role of Increased n-acetylaspartate Levels in Cancer.

J Natl Cancer Inst 2016 Jan 26;108(6):djv426. Epub 2016 Jan 26.

Departments of Gynecologic Oncology and Reproductive Medicine (BZ, RAP, RR, TM, ASN, HJD, WH, CI, SYW, KMG, SP, LSM, AMN, GAP, AKS), Cancer Systems Imaging (NMZ, CRM, PKB), Biostatistics (MG), Cancer Medicine (CVP), Center for RNA Interference and Non-Coding RNA (CI, LSM, CRA, GLB, AKS), Cancer Biology (YS, MBE, GLB, AKS), Experimental Therapeutics (CRA, GLB), Bioinformatics and Computational Biology (YW, KAB), Melanoma Medical Oncology (MAD), and Pathology (JL), University of Texas M. D. Anderson Cancer Center, Houston, TX; Department of Nanomedicine and Bioengineering, UT Health, Houston, TX (GLB, AKS); Departments of Psychology, Urology, and Obstetrics and Gynecology, the University of Iowa, Iowa City, IA (SKL); Laboratory for Systems Biology of Human Diseases (LY, JB, AA, DN), Department of Chemical and Biomolecular Engineering (LY, JB, AA, DN), and Department of Bioengineering (DN), Rice University, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849357PMC
January 2016

Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.

Cell Rep 2015 Dec 10;13(11):2395-2402. Epub 2015 Dec 10.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.11.047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691557PMC
December 2015

XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.

Clin Cancer Res 2015 Jul 15;21(14):3286-97. Epub 2015 Apr 15.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506247PMC
July 2015

Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.

J Natl Cancer Inst 2015 Jul 20;107(7). Epub 2015 May 20.

: Departments of Pathology (GL, DY, YS, XL, PJ, DC, LH, WZ), Experimental Therapeutics (CRA, GLB), and Gynecologic Oncology and Reproductive Medicine (RR, LSM, AKS), Division of Cancer Medicine (CVP), Center for RNAi and Non-Coding RNA (RR, CVP, LSM, CRA, GLB, AKS, WZ), the University of Texas MD Anderson Cancer Center, Houston, TX; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China (GL, YW, FX); Department of Pathology (YS) and Epidemiology (KC), Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University, Xi'an, China (XL); Institute for Systems Biology, Seattle, WA (IS); Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (LDC, DM).

View Article

Download full-text PDF

Source
http://academic.oup.com/jnci/article/doi/10.1093/jnci/djv108
Publisher Site
http://dx.doi.org/10.1093/jnci/djv108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554255PMC
July 2015

PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.

Mol Cancer Ther 2015 Jun 1;14(6):1466-1475. Epub 2015 Apr 1.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-1077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458384PMC
June 2015

MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.

J Pathol 2015 Jan 6;235(1):25-36. Epub 2014 Nov 6.

Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268369PMC
January 2015

Therapeutic silencing of KRAS using systemically delivered siRNAs.

Mol Cancer Ther 2014 Dec 3;13(12):2876-85. Epub 2014 Oct 3.

Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416486PMC
December 2014

Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.

Nat Commun 2014 Oct 29;5:5202. Epub 2014 Oct 29.

1] Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [2] Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [3] Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215647PMC
October 2014

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

Cancer Cell 2014 Jul;26(1):77-91

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-coding RNA, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100212PMC
July 2014

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer.

Clin Cancer Res 2014 Jun 22;20(12):3280-8. Epub 2014 Apr 22.

Authors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, WashingtonAuthors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, WashingtonAuthors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, Washington

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-0445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062703PMC
June 2014

Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.

Cell Rep 2014 Apr 3;7(2):488-500. Epub 2014 Apr 3.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.03.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038960PMC
April 2014

Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis.

Proc Natl Acad Sci U S A 2014 Apr 24;111(14):5331-6. Epub 2014 Mar 24.

Departments of Pharmacology, Obstetrics and Gynecology, and Surgery, and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.1317242111
Publisher Site
http://dx.doi.org/10.1073/pnas.1317242111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986124PMC
April 2014

Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer.

J Natl Cancer Inst 2013 Oct 23;105(19):1485-95. Epub 2013 Sep 23.

Affiliations of authors: Department of Gynecologic Oncology and Repro ductive Medicine (YK, WH, CI, CVP, HJD, BZ, TL, JH, NBJ, RR, MT, TM, SP, SYW, CL, YW, AKS), Center for RNAi and Non-Coding RNA (CI, AKS), Department of Pathology (JH, JL), and Department of Cancer Biology (AKS), The University of Texas MD Anderson Cancer Center, Houston, TX; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College of Fudan University, Shanghai, China (YK); Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (TL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787907PMC
October 2013

MicroRNA therapeutics: principles, expectations, and challenges.

Chin J Cancer 2011 Jun;30(6):368-70

Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013410PMC
http://dx.doi.org/10.5732/cjc.011.10186DOI Listing
June 2011